Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4

A legfontosabb adatok

Hol
Newark (Egyesült Államok)Mind a 2 helyszín megnézése

Helyszínek itt: Egyesült Államok

  • Newark Beth Israel Medical CenterNewark, Egyesült ÁllamokContact: Garrett GianneschiRésztvevőt keres
  • Rutgers New Jersey Medical School/University HospitalNewark, Egyesült ÁllamokContact: Garrett Gianneschi, DORésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Rutgers, The State University of New Jersey
Azonosító
NCT06797219
A regiszteradat frissítve
2025. július 22.
Eredeti leírás
The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by parents, retention rates, selection of most appropriate outcome measures, provide sample size estimates for a larger trial, increase the researchers\' experience with the study intervention. A complete list of objectives and aims are listed under "Objectives". This study hopes to treat 12-24 neonates using 650nm light of irradiance 10mW/cm2 for 5 minutes twice a day each day for 12 days. We will also call the parents at 6 months and 12 months to track developmental milestones.A teljes eredeti leírásKevesebb

The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by parents, retention rates, selection of most appropriate outcome measures, provide sample size estimates for a larger trial, increase the researchers\' experience with the study intervention. A complete list of objectives and aims are listed under "Objectives". This study hopes to treat 12-24 neonates using 650nm light of irradiance 10mW/cm2 for 5 minutes twice a day each day for 12 days. We will also call the parents at 6 months and 12 months to track developmental milestones.

Bevonási feltételek: neonates with intraventricular hemorrhage grade 3 or 4 less than 1 month old.

Kizáró feltételek: neonates without IVH grade 3/4 or older than 1 month.

ClinicalTrials.gov NCT06797219